Day: February 22, 2022

– Unprecedented CLEAR Outcomes Study Achieved 90% MACE Accumulation in February 2022 – – U.S. Net Product Revenue of NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets Grew 12% Sequentially to $12.2 Million in the Fourth Quarter 2021 and Over 200% for the Full Year 2021 – – Prescriptions Grew 9% During the Quarter; Approximately 70,000 Patients Have Filled a Prescription for NEXLETOL Tablets or NEXLIZET Tablets Since Launch – – Strengthened Capital Position in Fourth Quarter 2021 with $209 Million Financing Securing Path to CLEAR Outcomes Topline and Beyond – ANN ARBOR, Mich., Feb. 22, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a business update. “In 2021, Esperion strengthened its...

Highlights:Record net sales of $398.2 million for the quarter, up 32% year-over-year. Diluted earnings per share (“EPS”) of $1.07, compared to $1.11 in Q4 2020. Adjusted diluted EPS* of $1.33 compared to $1.19 in Q4 2020. For fiscal 2021, achieved record net sales, diluted EPS and adjusted diluted EPS*. For fiscal 2022, the Company expects net sales growth of 19%-22%, diluted EPS of $4.94 to $5.14, and adjusted diluted EPS* of $5.35 to $5.55.COLMAR, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ:DORM), a leading supplier in the automotive aftermarket industry, today announced its financial results for the fourth quarter ended December 25, 2021. Fourth Quarter Financial ResultsDorman reported quarterly net sales in the fourth quarter of 2021 of $398.2 million, up 32% compared...

– First New Drug Application (NDA) submission targeted in Q4 2022 for lead program SB206 (berdazimer gel 10.3%) for molluscum contagiosum – – Ongoing advancement of priority development pipeline assets SB019, for the treatment of SARS-CoV-2, toward a Phase 1 study in 2022, and SB204, for the treatment of acne vulgaris, toward a registrational Phase 3 study in 2023 – – Company to host update conference call and webcast today at 8:30 a.m. ET – DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced its financial and operating results for the year ended December 31, 2021 and provided a corporate update. The Company will host a conference call and webcast, today, February 22, 2022, at 8:30 a.m. ET (details below). “Over the course of 2021, we made significant progress across...

Delivered 7.2% annual revenue growth to $392.3 million in 2021, despite a reduction of $21.9 million of less profitable Non-Strategic Technology Services revenue Efficient execution of large training, implementation, and support engagement for a health system in North America drove better than expected fourth quarter results for North America IT Solutions and Services segment with $45.1 million in revenue – more than double prior-year period Gross margin expanded 100 basis points in the fourth quarter to 22.3% from increased contributions of IT solutions and services and continued disengagement from lower margin non-strategic technology servicesGAAP operating income for the quarter increased 54.6% with a margin of 4.6%, up 130 basis pointsFourth quarter GAAP diluted EPS of $0.58, which included a reversal of a tax valuation...

NASHVILLE, Tenn., Feb. 22, 2022 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December 31, 2021. The Company reported net income of $21.6 million, or $0.14 per diluted common share, for the quarter ended December 31, 2021. Normalized FFO for the three months ended December 31, 2021 totaled $64.6 million, or $0.44 per diluted common share and $246.1 million, or $1.71 per diluted common share for the year. Salient quarterly highlights include:Normalized FFO per share totaled $0.44, an increase of 5.3% from $0.42 in the fourth quarter of 2020. Same store cash NOI for the fourth quarter increased 2.7% over the prior year excluding the $0.3 million of fourth quarter 2020 deferral repayments. For the trailing twelve months ended December 31, 2021, same store cash...

Reported full-year 2021 net income of $25 million and EBITDA of $462 million, despite $435 million in RINs expense due to the broken Renewable Fuel Standard program that we are working diligently to repair. Improved environmental, health and safety performance year-over-year. Paid a special dividend valued at approximately $492 million, an equivalent of $4.89 per share, to CVR Energy stockholders during the second quarter of 2021. CVR Partners declared distributions of $9.89 per common unit for 2021, paid down $30 million in debt in 2021 and expects to pay down another $65 million in debt on February 22, 2022.SUGAR LAND, Texas, Feb. 22, 2022 (GLOBE NEWSWIRE) — CVR Energy, Inc. (“CVR Energy” or the “Company”) (NYSE: CVI) today announced a fourth quarter 2021 net loss of $14 million, or 14 cents per diluted share, on net sales...

Achieved a combined ammonia utilization rate of 92 percent across both fertilizer facilities for 2021. Strengthened the balance sheet by reducing outstanding debt by $95 million inclusive of the expected redemption of the remaining $65 million in 9.25% Senior Secured Notes on February 22, 2022. Declared a fourth quarter 2021 cash distribution of $5.24 per common unit, bringing the cumulative cash distributions declared for 2021 to $9.89 per common unit.SUGAR LAND, Texas, Feb. 22, 2022 (GLOBE NEWSWIRE) — CVR Partners, LP (“CVR Partners” or the “Partnership”) (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, today announced net income of $61 million, or $5.76 per common unit, on net sales of $189 million for the fourth quarter 2021, compared to a net loss of $17 million, or...

4Q HighlightsSales increase 47.4% to $1.1 billion, same branch revenue increases 12.5%Net income increases 10.7% to $78.4 million, and 44.9% on an adjusted basis$2.37 net income per diluted share, $3.12 on an adjusted basisAdjusted EBITDA margin expands 30 basis points to 17.1%, 19.0% on a same branch basis, up 220 basis pointsProvides 2022 Sales, Adjusted EBITDA Guidance and Long-Term AssumptionsDAYTONA BEACH, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada today reported results for the fourth quarter ended December 31, 2021. Robert Buck, President and Chief Executive Officer, stated, “We are pleased with our fourth quarter results. Our same branch...

Fourth quarter net revenue grew 13.8% with organic revenue growth of 13.9%Significant GAAP net income growth to +$4.3 million and Adjusted EBITDA grew 14.4% to $47.7 millionIntroduces 2022 guidance above our long term outlook CHARLOTTE, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) — Krispy Kreme, Inc. (NASDAQ: DNUT) (“Krispy Kreme” or the “Company”) today reported strong financial results for the fourth quarter and full year ended January 2, 2022 with fourth quarter net revenue growing 13.8% year-over-year, or 21.5% adjusted for the extra 53rd week in 2020. For the fourth quarter, organic revenue grew 13.9%, including the now fully-exited legacy wholesale business, or 19.6% excluding this business, year-over-year. For the full year, net revenue grew 23.4%, while organic revenue grew 12.5%, or 21.4% excluding the legacy wholesale business. GAAP...

Strong operating performance supported $0.06 EPS from continuing operations and $0.59 of adjusted EPS Achieved a strong quarter of cash flow, contributing to full year operating cash flow of $356 million and free cash flow of $277 million Positioned for separation into two independent public companies near the end of the first quarter 2022 with strong growth outlooks for both businessesWilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) —  Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the fourth quarter and fiscal year 2021 and provided additional updates. The Company reported fourth quarter net income from continuing operations of $10 million, or $0.06 per share, compared to $41 million, or $0.29 per share, in the prior year period. Adjusted earnings of $0.59...